ArticlePLoS computational biology2026
From prompts to genomes: A constraint-first framework for AI-driven sequence design across life and viruses.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A constraint-first framework for future 'prompt-to-genome' AI across Bacteria, Archaea, Eukaryota, and viruses is proposed. Genome-scale models can now generate long DNA sequences, and experimentally viable genome-scale designs have begun to appear, but sequence generation alone does not establish biological feasibility. Constraints should not require designs to remain within natural sequence space; rather, they should define testable boundaries for function, inheritance, lifecycle coherence and safe use, including new-to-nature designs. We propose a two-part system. First, a Constraint Compiler translates natural-language prompts into machine-checkable specifications defining scope, context, objectives, assumptions and governance requirements. Second, a modular Validator Stack (C1-C6) evaluates candidate designs for sequence integrity, gene and regulatory plausibility, genome completeness, comparative coherence, systems-level feasibility, and safety and governance. Extreme prompts serve as stress tests to expose hidden assumptions, conflicting objectives, and refusal points, complemented by adversarial testing and risk assessment. A phased roadmap and community benchmarks are proposed to measure specification accuracy, biological feasibility, robustness, and governance performance. The goal is to move prompt-to-genome systems from impressive generation toward reliable, auditable, and accountable biological design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.